Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-07

Clinical Trial Update: Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating gastrointestinal effects and health-related quality of life in kidney transplant patients treated with mycophenolate mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Novartis | Conditions: Maintenance Kidney Transplant | Phase 4 | Status: COMPLETED